newsfilter
← Latest News
GlobeNewswire·

Legend Biotech Reports First Quarter 2026 Results and Recent Highlights

CARVYKTI® (ciltacabtagene autoleucel; cilta-cel) net trade sales increased 62% versus first quarter of 2025 to approximately $597 millionCARVYKTI® now available across 18 global markets, following recent